Pathologist
Pathology
Dr. Wareef Kabbani, MD
|
|
Give Review
Wareef Kabbani is an expert in the field of Pathology. He went to medical school at Wayne State University School of Medicine. Wayne State University School of Medicine has a rank of 63 in research and a 85 in primary care Wareef Kabbani is a published MD. He has 53 papers published. The most current publication "BAP1 loss defines a new class of renal cell carcinoma."
Publications
- BAP1 loss defines a new class of renal cell carcinoma.
- A validated tumorgraft model reveals activity of dovitinib against renal cell carcinoma.
- Upper urinary tract urothelial carcinoma with loco-regional nodal metastases: insights from the Upper Tract Urothelial Carcinoma Collaboration.
- Interplay between pVHL and mTORC1 pathways in clear-cell renal cell carcinoma.
- Bilharzial vs non-bilharzial related bladder cancer: pathological characteristics and value of cyclooxygenase-2 expression.
- Irreversible electroporation (IRE): a novel method for renal tissue ablation.
- Primary adenocarcinoma of the urinary bladder: value of cell cycle biomarkers.
- Tissue compression analysis for magnetically anchored cautery dissector during single-site laparoscopic cholecystectomy.
- Cell-Type-Dependent Regulation of mTORC1 by REDD1 and the Tumor Suppressors TSC1/TSC2 and LKB1 in Response to Hypoxia.
- Urinary cytology for the detection of urothelial carcinoma of the bladder--a flawed adjunct to cystoscopy?
- Evidence of epithelial to mesenchymal transition associated with increased tumorigenic potential in an immortalized normal prostate epithelial cell line.
- Prognostic value of cyclooxygenase-2 expression in squamous cell carcinoma of the bladder.
- Expression of cell cycle-related molecular markers in patients treated with radical cystectomy for squamous cell carcinoma of the bladder.
- Magnetic anchoring and guidance system instrumentation for laparo-endoscopic single-site surgery/natural orifice transluminal endoscopic surgery: lack of histologic da...
- Effect of the Bethesda system for reporting thyroid cytopathology on thyroidectomy rates and malignancy risk in cytologically indeterminate lesions.
- Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy.
- Prostate cancer radiosensitization through poly(ADP-Ribose) polymerase-1 hyperactivation.
- Off-label high-risk HPV DNA testing of vaginal ASC-US and LSIL cytologic abnormalities at Parkland hospital.
- Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract.
- Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis.
- Sirolimus and temsirolimus for epithelioid angiomyolipoma.
- Optical reflectance spectroscopy for detection of human prostate cancer.
- Renal phosphate wasting due to tumor-induced osteomalacia: a frequently delayed diagnosis.
- Assessment of the minimum number of lymph nodes needed to detect lymph node invasion at radical nephroureterectomy in patients with upper tract urothelial cancer.
- Comparison of tissue oxygenation profiles using 3 different methods of vascular control during porcine partial nephrectomy.
- A comparison of kidney oxygenation profiles between partial and complete renal artery clamping during nephron sparing surgery in a porcine model.
- Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy.
- Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration.
- Fulminant hepatic failure due to nilutamide hepatotoxicity.
- Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients.
- Intratumoral delivery of beta-lapachone via polymer implants for prostate cancer therapy.
- Does topical haemostatic agent have an adverse effect on the function of the prostatic neurovascular bundle?
- Conservative management in selected patients with upper tract urothelial carcinoma compares favourably with early radical surgery.
- Sirolimus in metatastic renal cell carcinoma.
- Focal radiofrequency coagulation-assisted laparoscopic partial nephrectomy: a novel nonischemic technique.
- Absence of viable renal carcinoma in biopsies performed more than 1 year following radio frequency ablation confirms reliability of axial imaging.
- Pseudosarcomatous fibromyxoid tumor of the bladder.
- Selective prostate cancer thermal ablation with laser activated gold nanoshells.
- Prognostic value of syndecan-1 expression in patients treated with radical prostatectomy.
- Rectal GI stromal tumor mimicking a prostate mass.
- Enhanced therapeutic effect on androgen-independent prostate cancer by depsipeptide (FK228), a histone deacetylase inhibitor, in combination with docetaxel.
- A histone deacetylase inhibitor enhances adenoviral infection of renal cancer cells.
- Nodular hidradenocarcinoma over the parotid gland: a pathologic presentation.
- Efficacy of ablative high-dose-per-fraction radiation for implanted human renal cell cancer in a nude mouse model.
- Efficacy of high dose per fraction radiation for implanted human prostate cancer in a nude mouse model.
- Gastrointestinal hemorrhage as first manifestation of metastatic testicular tumor.
- Application of novel hemostatic agent during laparoscopic partial nephrectomy.
- Retrograde renal cooling during radio frequency ablation to protect from renal collecting system injury.
- Uterine tumor resembling ovarian sex-cord tumor: report of a case mimicking cervical adenocarcinoma.
- Cell block findings from residual PreservCyt samples in unsatisfactory ThinPrep Paps: no additional benefit.
- Mucinous and nonmucinous appendiceal adenocarcinomas: different clinicopathological features but similar genetic alterations.
- Origin and racial distribution of glandular tissue in the anterior compartment of the prostate: an autopsy study.
Doctors Specialties
- Cytopathology
- Pathology
Accepted Insurances
Education
-
University of Texas Southwestern Medical School -
University of Texas MD Anderson Cancer Center -
Wayne State University School of Medicine -
University of Aleppo Faculty of Medicine
Hospital
-
Methodist Richardson Medical Center
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1093784548 |
| Last Name Of The Provider | KABBANI |
| First Name Of The Provider | WAREEF |
| View All |
Similar Doctors
|
|
Dr. Bahram R. Oliai, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Karen R. Pinto, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph L. Sailors, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anita L. Sengupta, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Craig C. Childs, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Terri W. Crook, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yan Peng, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dale S. Odell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Beverly A. Dickson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ghazi S. Zaatari, MD |
|
|
Dr. Jana C. Sullinger, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Horace C. Wu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maria Alvi, MD
This Doctor is OpenDoctor Recommended.
|